PARIS, France (AFP) — French pharmaceuticals giant Sanofi and Britain’s GSK reported on Monday “strong immune responses” in early tests of their Covid-19 vaccine, raising hopes it could join the fight against the pandemic. The companies said the results of the Phase 2 study will enable them to move to a late-stage trial in the coming weeks — a reversal of fortune after their research was dealt a setback late last year. The experimental vaccine […]